- XPOVIO® is the first and only approved XPO1 inhibitor in Indonesia. - From the second half of 2024 to now, XPOVIO® was successively approved in Thailand, Malaysia and Indonesia, significantly expanding Antengene's commercial presence in APAC. To date, XPOVIO® has been approved for...
Read More Details
Finally We wish PressBee provided you with enough information of ( XPOVIO® (selinexor) Approved for Commercialization in Indonesia, Further Expanding Antengene's Commercial Presence in APAC )
Also on site :
- Hamas agrees to release 10 hostages as Trump says there’s a ‘very good chance’ for ceasefire deal this week
- '80s Country Hitmaker Marks 'Well Deserved' Career Milestone 12 Years After Stroke
- 1 in custody, no shots fired: Police respond to Gaylord Rockies Resort Center Wednesday